Ad
related to: ortho molecular log in portal patient site page
Search results
Results From The WOW.Com Content Network
American chemist Linus Pauling coined the term "orthomolecular" in the 1960s to mean "the right molecules in the right amounts" (ortho-in Greek implies "correct"). [11] Proponents of orthomolecular medicine hold that treatment must be based on each patient's individual biochemistry. [12] [13]
The Journal of Orthomolecular Medicine is not indexed by MEDLINE, a database of biomedical literature.Journals are selected for MEDLINE by the National Library of Medicine based on scope and coverage, quality of content, quality of editorial work, intended audience, quality of the layout, printing, graphics, and illustrations. [6]
[2] [3] Orthomolecular psychiatry's goal of weaning patients from conventional neuroleptic drugs [4] follows "Pfeiffer's Law", "For every drug that benefits a patient, there is a natural substance that can achieve the same effect". [5] In 1968, Linus Pauling first used the term orthomolecular. [6] [7]
The major shortcoming of most patient portals is their linkage to a single health organization. If a patient uses more than one organization for healthcare, the patient typically needs to log on to each organization's portal to access information. This results in a fragmented view of individual patient data. [3]
Ortho Clinical Diagnostics (now QuidelOrtho) is an in vitro diagnostics company that made products and diagnostic equipment for blood testing.Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion ...
Molecular genetic testing provides patients and their doctors with accurate diagnosis of a broad range of cancers, infectious diseases, and inherited conditions. By identifying the exact molecular genetic alterations or biomarkers in a patient’s specimen, molecular genetic testing can identify treatment targets for personalized precision ...
Ortho-McNeil was found liable in two 2013 civil suits by women who gave birth to children with birth defects after taking Topamax while pregnant. The jury found that they negligently failed to warn the patients and their doctors of the risks associated with Topamax when used by patients during pregnancy. [ 5 ]
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions: Ortho-McNeil , based in Raritan, NJ (United States); the division is focused on primary care .